エペリゾン (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "エペリゾン" in Japanese language version.

refsWebsite

Global rank Japanese rank

4^th place

24^th place

2^nd place

6^th place

6,690^th place

394^th place

1europeanreview.org

low place

low place

1curehunter.com

low place

low place

low place

low place

low place

low place

1clinicaltrials.gov

5,225^th place

low place

low place

low place

low place

low place

610^th place

915^th place

clinicaltrials.gov (Global: 5,225^th place; Japanese: low place)

臨床試験番号 NCT00327730 研究名 "Evaluation of Eperisone HCl in the Treatment of Acute Musculoskeletal Spasm Associated With Low Back Pain" - ClinicalTrials.gov

com.bd (Global: low place; Japanese: low place)

squarepharma.com.bd

http://squarepharma.com.bd/SPL_PI_PDF/myonil226.pdf

curehunter.com (Global: low place; Japanese: low place)

http://www.curehunter.com/public/keywordSummaryC030848--4--ethyl-2-methyl-3-piperidino-propiophenone.do

doi.org (Global: 2^nd place; Japanese: 6^th place)

Yang SI, Park HY, Lee SH (July 2004). “Transdermal eperisone elicits more potent and longer-lasting muscle relaxation than oral eperisone”. Pharmacology 71 (3): 150–6. doi:10.1159/000077449. PMID 15161997.
Bose K (1999). “The efficacy and safety of eperisone in patients with cervical spondylosis: Results of a randomized, double-blind, placebo-controlled trial”. Methods Find Exp Clin Pharmacol 21 (3): 209–13. doi:10.1358/mf.1999.21.3.534831. PMID 10389124.
Tanno K, Narimatsu E, Takeyama Y, Asai Y (May 2007). “Infantile case of seizure induced by intoxication after accidental consumption of eperisone hydrochloride, an antispastic agent”. Am J Emerg Med 25 (4): 481–2. doi:10.1016/j.ajem.2006.09.002. PMID 17499672.

elsevier.com (Global: 610^th place; Japanese: 915^th place)

linkinghub.elsevier.com

Tanno K, Narimatsu E, Takeyama Y, Asai Y (May 2007). “Infantile case of seizure induced by intoxication after accidental consumption of eperisone hydrochloride, an antispastic agent”. Am J Emerg Med 25 (4): 481–2. doi:10.1016/j.ajem.2006.09.002. PMID 17499672.

europeanreview.org (Global: low place; Japanese: low place)

P. Cabitza, P. Randelli., Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study. Eur Rev Med Pharmacol Sci 2008; 12 (4): 229-235

jsaweb.jp (Global: low place; Japanese: low place)

jja.jsaweb.jp

上野孝, 川名誠司 (2007-07). “びまん性紅斑と血管浮腫を呈した塩酸エペリゾン（ミオナール）による薬疹の1例”. アレルギー 56 (7): 709–13. PMID 17671415.

nih.gov (Global: 4^th place; Japanese: 24^th place)

pubmed.ncbi.nlm.nih.gov

Yang SI, Park HY, Lee SH (July 2004). “Transdermal eperisone elicits more potent and longer-lasting muscle relaxation than oral eperisone”. Pharmacology 71 (3): 150–6. doi:10.1159/000077449. PMID 15161997.
Bose K (1999). “The efficacy and safety of eperisone in patients with cervical spondylosis: Results of a randomized, double-blind, placebo-controlled trial”. Methods Find Exp Clin Pharmacol 21 (3): 209–13. doi:10.1358/mf.1999.21.3.534831. PMID 10389124.
上野孝, 川名誠司 (2007-07). “びまん性紅斑と血管浮腫を呈した塩酸エペリゾン（ミオナール）による薬疹の1例”. アレルギー 56 (7): 709–13. PMID 17671415.
Tanno K, Narimatsu E, Takeyama Y, Asai Y (May 2007). “Infantile case of seizure induced by intoxication after accidental consumption of eperisone hydrochloride, an antispastic agent”. Am J Emerg Med 25 (4): 481–2. doi:10.1016/j.ajem.2006.09.002. PMID 17499672.

pmda.go.jp (Global: 6,690^th place; Japanese: 394^th place)

info.pmda.go.jp

“ミオナール錠50mg／ミオナール顆粒10% 添付文書” (2012年6月). 2016年6月27日閲覧。
“ミオナール錠50mg／ミオナール顆粒10% インタビューフォーム” (PDF) (2012年6月). 2016年5月26日閲覧。

prous.com (Global: low place; Japanese: low place)

journals.prous.com

Bose K (1999). “The efficacy and safety of eperisone in patients with cervical spondylosis: Results of a randomized, double-blind, placebo-controlled trial”. Methods Find Exp Clin Pharmacol 21 (3): 209–13. doi:10.1358/mf.1999.21.3.534831. PMID 10389124.

wikipedia.org (Global: low place; Japanese: low place)

en.wikipedia.org

臨床試験番号 NCT00327730 研究名 "Evaluation of Eperisone HCl in the Treatment of Acute Musculoskeletal Spasm Associated With Low Back Pain" - ClinicalTrials.gov